Product
Personalized tumor vaccine
1 clinical trial
1 indication
Indication
Follicular LymphomaClinical trial
Pilot Study of a Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular LymphomaStatus: Terminated, Estimated PCD: 2020-09-24